Search
Saturday 8 August 2015
  • :
  • :
Latest Update

Afternoon Trade News Report on: Cousins Properties Inc (NYSE:CUZ), Arch Coal Inc (NYSE:ACI), Monogram Residential Trust Inc (NYSE:MORE), Cerus Corporation (NASDAQ:CERS)

On Friday, in the course of current trade, Shares of Cousins Properties Inc (NYSE:CUZ), dropped -0.20%, and is now trading at $9.85.

Cousins Properties Incorporated, declared that it has signed a 15-year build-to-suit lease with NCR Corporation (NCR), a leader in consumer transaction technologies, for the company’s world headquarters building. Cousins will develop and own the about $200 million, 485,000 square foot building located in the Midtown submarket of Atlanta which is 100 percent pre-leased to NCR.

“We are thrilled to be working with NCR to build their world headquarters in Midtown Atlanta,” said Larry Gellerstedt, President and Chief Executive Officer of Cousins Properties. “This is an exceptional opportunity for Cousins to develop and own a cutting edge, skyline-enhancing trophy tower in Atlanta’s leading technology district.”

Cousins Properties Incorporated, a real estate investment trust (REIT), owns, develops, and manages real estate portfolio, in addition to performs certain real estate-related services in the United States.

During an Afternoon trade, Shares of Arch Coal Inc (NYSE:ACI), dipped -0.76%, and is now trading at $1.30.

Arch Coal, declared the extension of its (i) pending private offer to exchange (the “2020 Exchange Offer”) new 6.25% Trust Certificates due 2021 (the “Trust Certificates”) and a cash payment for any and all of its outstanding 7.25% Senior Notes due 2020 (the “2020 Notes”) and (ii) pending concurrent private offer to exchange (the “Concurrent Exchange Offer” and, together with the 2020 Exchange Offer, the “Exchange Offers”) Trust Certificates, 8.00% Senior Secured Notes due 2022 (the “New 2022 Secured Notes”) and 12.00% Senior Secured Second Lien Notes due 2023 (the “New 2023 Secured Notes”) for its outstanding 7.000% Senior Notes due 2019 (“Old 7.000% 2019 Notes”), 9.875% Senior Notes due 2019 (“Old 9.875% 2019 Notes”) and 7.250% Senior Notes due 2021 (“Old 7.250% 2021 Notes” and, together with the Old 7.000% 2019 Notes and the Old 9.875% 2019 Notes, the “Old Notes”).

The 2020 Exchange Offer, formerly set to expire at 12:00 midnight, New York City time, on August 4, 2015, has been extended and is now set to expire at 12:00 midnight, New York City time, on August 14, 2015. The Concurrent Exchange Offer, formerly set to expire at 12:00 midnight, New York City time, on August 4, 2015, has been extended and is now set to expire at 12:00 midnight, New York City time, on August 14, 2015. Additionally, the Early Tender Time for the Concurrent Exchange Offer, formerly set to expire at 12:00 midnight, New York City time, on August 4, 2015, has been extended and is now set to expire at 12:00 midnight, New York City time, on August 14, 2015. The Withdrawal Deadline for the Exchange Offers has passed, so 2020 Notes tendered in the 2020 Exchange Offer and Old Notes tendered in the Concurrent Exchange Offer may no longer be withdrawn.

Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled about 5.1 billion tons of proven and probable recoverable reserves.

Shares of Monogram Residential Trust Inc (NYSE:MORE), during its Friday’s current trading session fell - 0.93%, and is now trading at $9.56.

Monogram Residential Trust, stated operational and financial results for the second quarter 2015.

“We are happy with our strong second quarter results, which reflect continued growth across our portfolio. Second quarter Core FFO grew by 60%, and we stated solid enhances in rental revenue, NOI, and occupancy rates, which allowed us to enhance our target for full year 2015 Same Store NOI growth,” stated Mark T. Alfieri, Chief Executive Officer, President, Chief Operating Officer and Director of Monogram. “Additionally, we continued to execute on our strategy to grow our wholly owned portfolio through the purchase of interests in seven joint ventures during the quarter. We are also happy that we were able to execute two dispositions of stabilized communities in Chicago and Houston at attractive pricing and sold our interests in a development in the D.C. market, which will allow us to redeploy capital into our core markets. Looking toward the balance of the year, we are uniquely positioned to outperform as we drive organic growth from our high quality, young portfolio in addition to benefit from the value creation within our development pipeline and joint venture acquisitions.”

Monogram Residential Trust, Inc. is an equity real estate investment trust. The trust invests in the real estate markets of United States. It engages in investment, development and operation of real estate assets.

Finally, Cerus Corporation (NASDAQ:CERS), lost -2.41% Friday.

Cerus Corporation, declared financial results for the second quarter ended June 30, 2015.

Recent company highlights comprise:

  • Second quarter disposable kit demand raised 32% year over year.
  • Signed INTERCEPT platelet and plasma supply agreements with Unyts and Bonfils Blood Center.
  • Suncoast Blood Bank produced the first INTERCEPT pathogen reduced platelet components distributed in the continental United States.
  • Designated Richard J. Benjamin, MD, PhD as chief medical officer.
  • Received FDA approval of Phase IV PIPER study protocol.
  • Presented at AABB Symposium on Implementation of Pathogen-Reduced Blood Components (April 27-28, Bethesda, Maryland).

Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *